Amneal Pharmaceuticals, Inc. AMRX Affordable Medicines — Materials and supplies
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SuppliesExpense.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s affordable medicines — materials and supplies.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s affordable medicines — materials and supplies?
- Amneal Pharmaceuticals, Inc. (AMRX) reported affordable medicines — materials and supplies of $8.82M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s affordable medicines — materials and supplies changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s affordable medicines — materials and supplies increased by 3.4% year-over-year, from $8.53M to $8.82M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s affordable medicines — materials and supplies?
- Over 3 years (2022 to 2025), Amneal Pharmaceuticals, Inc.'s affordable medicines — materials and supplies has grown at a -1.4% compound annual growth rate (CAGR), from $32.91M to $31.57M.
- What does affordable medicines — materials and supplies mean?
- Represents the direct costs associated with raw materials, components, and supplies required for pharmaceutical manufacturing within the segment. This is a critical component of the cost of goods sold and reflects supply chain cost management.